Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s share price shot up 0.2% on Tuesday . The stock traded as high as $4.54 and last traded at $4.52. 18,118 shares changed hands during trading, a decline of 93% from the average session volume of 262,103 shares. The stock had previously closed at $4.51.
Ono Pharmaceutical Trading Up 0.2%
The stock has a fifty day moving average of $4.06 and a 200 day moving average of $3.80.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Stories
- Five stocks we like better than Ono Pharmaceutical
- Market Cap Calculator: How to Calculate Market Cap
- Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?
- What Does a Stock Split Mean?
- Checkmate in the Cloud: ServiceNow’s Shopping Spree
- How to Invest in Insurance Companies: A Guide
- The Contrarian Case for MSTR Amid MSCI Delisting Debacle
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
